Phil Ferneau is the Co-Founder and Managing Partner of Borealis Ventures. See sector focus and contact routes.
Phil Ferneau is the Co-Founder and Managing Partner of Borealis Ventures, an early-stage healthcare venture capital firm based in Hanover, New Hampshire, where he has led the firm’s healthcare investing from its inception. His investment thesis targets Seed and Series A stages across life science platforms, digital health, and animal health sectors, with a primary geographic focus on the United States. While specific check sizes and lead/follow behavior are not publicly detailed, Ferneau personally leads investments in portfolio companies including Adimab, Evox Therapeutics, Compass Therapeutics, and Teckro. Notable past investments under his leadership include Avedro (Nasdaq: AVDR), GlycoFi (acquired by Merck & Co.), and Vets First Choice (Nasdaq: CVET). Before founding Borealis, Ferneau spent over 20 years advancing innovation ecosystems at Dartmouth College, serving as the founding Executive Director of the Center for Private Equity and Entrepreneurship at the Tuck School of Business. He remains an adjunct faculty member at Tuck teaching venture capital and began his career in private legal practice counseling technology startups and Fortune 500 companies
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Hanover.
Investors like Phil Ferneau · Full investor directory · Investor access · Company funding database